Compare ThredUp Inc (TDUP) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ThredUp Inc vs GeneDx Holdings Corp — how do they compare? ThredUp Inc trades at $3.17 (market cap $405.82M), while GeneDx Holdings Corp trades at $78.16 (market cap $2.45B). The key difference: GeneDx Holdings Corp is far larger — about 6× ThredUp Inc's market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, ThredUp Inc nearer its low. Which is the better fit depends on your goals.
| TDUP | WGS | |
|---|---|---|
Market Cap | $405.82M | $2.45B |
Sector | Consumer Cyclical | Technology |
52-Week High | $12.08 | $167.51 |
52-Week Low | $3.08 | $34.51 |
Enterprise Value | $404.00M | $2.49B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ThredUp (TDUP) trades at $3.17, up 0.96% on the day, but remains under pressure after a significant Q2 2026 earnings miss and lowered full-year revenue guidance. The stock's technical picture is bearish, while fundamentals show improving revenue growth but persistent losses. Recent news highlights an ongoing securities investigation related to the guidance revision, contributing to negative sentiment.
The outlook is cautious. While analyst consensus is technically 'Buy' (57% of ratings), recent operational setbacks and the stock's sharp decline post-earnings suggest significant near-term risk. The primary opportunity lies in the company's high gross margins and active buyer growth, but profitability remains elusive and investor confidence is fragile.
GeneDx Holdings Corp (WGS) trades at $82.39, up 0.8% today, with a bullish technical signal and strong analyst support. Recent Q2 2026 results beat expectations with $0.01 EPS versus a projected loss, and revenue reached $114.4 million. However, the company shows negative net income margins and high valuation multiples, alongside ongoing class action lawsuits creating headwinds.
The outlook is mixed: robust revenue growth and institutional buying signal potential, but profitability challenges and legal risks warrant caution. With a consensus price target of $79.25 below the current price, near-term pressure may persist despite long-term optimism from 91% buy ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ThredUp Inc
ThredUp Inc is an online resale platform for women and kids apparel, shoes, and accessories. It generates revenue from items that are sold to buyers through the website, mobile app, and RaaS partners.
Read more on TDUP →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
